Montis Biosciences • Beyond complement
Montis Biosciences develops cutting-edge C1q-targeting antibody therapies for neuroinflammatory diseases and cancer.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricing
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Food technology company creating plant-based meat and dairy products that replicate the taste and...
